The AIRR Community is pleased to announce the addition of a new Type 1 Diabetes (T1D) focused repository in the AIRR Data Commons. This is a collaboration between the iReceptor team (Simon Fraser University), The Sugar Science group, the Aaron Michels Lab (University of Colorado), and the Todd Brusko Lab (University of Florida) among others. This repository contains the first fully HLA/MHC genotyped study that adheres to the the AIRR v1.4 MHC genotype standard, with over 62 million annotated sequences from 359 repertoires from the Mitchell et al. longitudinal study of TCR repertoires (TRB locus) in children who progressed to T1D. This new T1D AIRR-seq data is searchable through the iReceptor Gateway and there is of course more T1D data to come from this collaboration. We encourage the community to share this valuable type of data!
On AIRR Podcast Episode 10 Now Available!
A new episode of #OnAIRR – the podcast of the AIRR Community is now available. Prof Ralf Küppers, @UniklinikEssen, Germany discusses AIRR-Seq in understanding B cell lymphomas. Building upon Ralf’s background in B cell differentiation in health and pathogenesis of human B cell lymphomas, we discuss how micro-dissection and Sanger sequencing is still the method of choice when analysing Hodgkin lymphoma and the V-gene usage and mutations in CLL as prognostic indicators before talking about tracking pathogenic clones when surveying for relapse during clinical follow up.
Subscribe and listen in your favourite app or check out all of the On AIRR episodes here: http://onairr.airr-community.org
On AIRR Podcast Episode 9 Available Now
Interested in studies of the adaptive immune receptor repertoire (AIRR)? Catch up on the latest in this new episode of On AIRR – An AIRR-C Podcast Series. Dr. Ulrik Stervbo and Dr. Zhaoqing Ding sit down with Vadim Nazarov the Co-Founder & CEO of the startup ImmunoMind to discuss the use of AI for repertoire insights.
Check out On AIRR Podcast #9 The ImmunoMind or wielding an AI for repertoire insights with Vadim Nazarov.
Join us for the next AIRR-C webinar on Nov 15th!
Machine learning for the analysis of adaptive immune receptors and repertoires
Speakers: Maria Chernigovskaya, University of Oslo and Milena Pavlović, University of Oslo
Adaptive immune receptor repertoires (AIRRs) capture past and present immune responses and therefore represent a powerful resource for developing diagnostics and therapeutics. Machine learning (ML) has the ability to discover complex sequence patterns and help further these diagnostic and therapeutic aims. However, to exploit these opportunities, it is necessary to overcome the intrinsic challenges of AIRR data: unknown rules determining antigen binding, high diversity and specificity of receptors with low overlap between AIRRs, and low signal-to-noise ratio. Further, different ML approaches need to be validated and compared before they could be deployed in practice. In this webinar, we will focus on standardized and reproducible ML workflows, benchmarking, and comparison of AIRR ML approaches. We will argue for the use of simulation for validation and benchmarking of ML methods before moving to experimental datasets.
Maria Chernigovskaya is a PhD candidate supervised by Prof. Victor Greiff and Prof. Geir Kjetil Sandve at the University of Oslo, Norway. Maria is working on a methodology for simulating synthetic adaptive immune receptor repertoire (AIRR) datasets to guide the development and benchmarking of AIRR-based machine learning.
Milena Pavlović is a postdoctoral researcher in the Sandve lab at the University of Oslo working on machine learning, causal inference, and their application to biomedical domains. During her PhD, Milena developed the immuneML platform (https://immuneml.uio.no) for the analysis of adaptive immune receptors and repertoires (AIRR), focusing on model robustness and reproducibility, and examined how the knowledge of the data generating process and the causal inference framework could improve AIRR machine learning diagnostics.
Registration is open!
On AIRR Podcast Episode 8 Available Now
In the latest episode of the On AIRR – An AIRR-C Podcast Series, Dr. Ulrik Stervbo and Dr. Zhaoqing Ding sit down with Dr. Adi Barzel, an associate professor of Biochemistry & Molecular Biology at Tel Aviv University and president of the Israeli Society of Gene and Cell Therapy. They discuss the therapeutic potential of engineered B cells as well as some of the problems with CRISPR-Cas9 gene editing.
You can listen to the episode (as well as past episodes) here or wherever you may find your podcasts. There are another three episodes scheduled for later this fall. If you share podcast-related content in social media, please remember to use the hashtag #onairr!